baber/WOPTO huggingface dataset:
Patent AU-2020218353-B2 (AU)
Title: Tibial fixation plate
Inventor: WOTTON III HAROLD M
IPC: A61B17/80
Filed: 2020-02-07
Granted: 2022-03-24
Abstract: A fixation plate includes a head section, a curved section, and a tail section. The head section includes one or more head apertures formed therethrough. The head apertures are configured to allow screws to respectively pass therethrough at varying angles to attach the head section to a first bone segment. The head section has a bottom surface that is configured to sit flush with the first bone segment. The curved section extends from the head section. The tail section extends from the curved section. The tail section includes one or more tail apertures formed therethrough. The tail apertures are configured to allow screws to respectively pass therethrough at varying angles to attach the tail section to a second bone segment.
Patent AU-2020237554-B2 (AU)
Title: Rigid-hulled inflatable boat
Inventor: YULE FRASER
IPC: B63B7/08
Filed: 2020-03-12
Granted: 2022-09-01
Abstract: An inflatable boat comprising a rigid hull and a sponson assembly slidably attached to the rigid hull. The sponson assembly comprising a plurality of elongate inflatable modular units, each of the modular units having at least one chamber inflatable by air, and the modular units are engagable to each other in an end-to-end relationship. The sponson assembly also comprises an inflatable bow sponson is also slidably attached to the rigid hull, and engagable with two of the modular units.
Patent AU-2020245142-B2 (AU)
Title: Controlling exhaust gas pressure of a plasma reactor for plasma stability
Inventor: LEONARD III GEORGE STEPHEN
IPC: H01J37/32
Filed: 2020-02-29
Granted: 2023-09-21
Abstract: The present invention provides a plasma generating system (100) having plasma reactors (101a - 101n). Each plasma reactor (101a) includes: a waveguide (120) for transmitting a microwave energy therethrough; a plasma chamber (122a) coupled to the waveguide (120) and configured to generate plasma (146) therein; a flow inlet (144) for introducing gas into the plasma chamber (122a); an exhaust gas pipe (125a) for carrying exhaust gas from the plasma chamber (122a), wherein the plasma (146) converts the gas into the exhaust gas; and a pressure control device (300) installed in the exhaust gas pipe (125a) and configured to control the pressure of the exhaust gas in the exhaust gas pipe (125a). The plasma generating system (100) also includes a manifold (127) coupled to the exhaust gas pipes (125a - 125n) of the plasma reactors (101a - 101n) and configured to receive the exhaust gas from the exhaust gas pipes (125a - 125n).
Patent AU-2020259627-B2 (AU)
Title: An oral cannabinoid tablet
Inventor: BRUUN HEIDI ZIEGLER
IPC: A61K9/20
Filed: 2020-04-17
Granted: 2023-09-21
Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non- DC particles providing the tablet with a plurality of discrete non-DC areas.
Patent AU-2021200722-B2 (AU)
Title: Method for Preparing a Flour Tortilla
Inventor: KARREMANS ADRIANUS RUTGERUS ANTONIUS
IPC: A21D13/42
Filed: 2021-02-04
Granted: 2022-03-17
Abstract: The invention relates to a method for preparing a flour tortilla, comprising 
- preparing a tortilla dough from cereal flour and fat particles, 
which fat particles at least substantially consist of triglycerides 
of saturated fatty acids having 8-22 carbon atoms; 
-shaping the tortilla dough into a tortilla shape; and 
- heating the shaped tortilla dough, thereby obtaining the flour 
tortilla.  
The invention further relates to a flour tortilla dough, comprising fat 
particles dispersed therein, which fat particles at least substantially consist 
of triglycerides of saturated fatty acids having 8-22 carbon atoms, and to a 
flour tortilla that can be obtained by a method according to the invention or 
made from dough according to the invention.
Patent AU-2021202634-B2 (AU)
Title: Hla-b57 open conformers
Inventor: MARROQUIN BELAUNZARAN OSIRIS
IPC: C07K14/74
Filed: 2021-04-28
Granted: 2022-09-15
Abstract: AUB-A-28042021 
Abstract 
The invention relates to a HLA-B57 open conformer or a HLA-B57 Fc fusion protein for use in 
the treatment or prevention of cancer. The Fc open conformer comprises or consists of a first 
and a second monomer, and each monomer comprises a HLA-B57 chain. The Fc fusion 
protein further comprises a protein stabilizing polypeptide sequence and optionally an amino 
acid linker. Further aspects of the invention provide combination medicaments comprising the 
HLA-B57 Fc open conformer and immune checkpoint inhibitors and/or checkpoint agonist 
agents.  
Furthermore, the invention relates to the use of HLA-B57 open conformer as an 
immunomodulator, particularly in diseases where modulation of diverse immune cell 
components (e.g. cytotoxic CD8+ T cells, Tregs) is a therapeutic strategy, e.g. infectious 
diseases.
Patent AU-2021202650-B2 (AU)
Title: Compositions and method for destabilizing, altering, and dispersing biofilms
Inventor: RICKARD ALEXANDER
IPC: A61K31/198
Filed: 2021-04-28
Granted: 2022-09-08
Abstract: The present disclosure relates to compositions and methods for destabilizing biofilms, 
altering biofilm 3D structure, and dispersing biofilms, in order to enhance biofilm cell 
removal and/or sensitivity to other agents (e.g., environmental or co-applied treatments). In 
particular, the present disclosure relates to the use of L-arginine in the removal and/or 
sensitization (e.g., to antimicrobials) of microorganisms in medical, industrial, domestic, or 
environmental applications, as well as treatment of bacterial infections (e.g., in biofilms).
Patent AU-2021203973-B2 (AU)
Title: Modular units, clamping assemblies, and slicing machines equipped therewith
Inventor: GEREG DUSTIN JOSEPH
IPC: B26D7/26
Filed: 2021-06-15
Granted: 2022-12-15
Abstract: B8-5103-PCT 
ABSTRACT OF THE DISCLOSURE 
A modular unit configured for mounting to a cutting head of a slicing 
machine and for securing a knife to the cutting head, and slicing machines equipped 
with one or more of such modular units. The modular unit includes mounting blocks 
adapted to be spaced apart in an axial direction of the cutting head, and a clamping 
assembly assembled with the mounting blocks so as to be between the mounting 
blocks. The clamping assembly is configured to secure a knife to the cutting head, 
and at least portions of the clamping assembly may be removable from the cutting 
head by disassembling the clamping assembly from the mounting blocks without 
removing the mounting blocks from the cutting head.  
- 21 -
Patent AU-2021240268-B2 (AU)
Title: Tugboat
Inventor: BANGSLUND THOMAS
IPC: B63B21/54
Filed: 2021-09-30
Granted: 2023-05-04
Abstract: TUGBOAT 
Described is a line handling system 10 for locating on a tugboat, wherein the tugboat 1 is 
for assisting a marine vessel 2 to manoeuvre. The tugboat 1 comprises a hull 11 having 
a perimeter P. The line handling system 10 comprises a line guide mechanism 100. The 
line guide mechanism 100 protrudes, or is positionable to protrude, away from the hull 
11 for guiding a line 20 of the marine vessel 2 towards a predetermined region R of the 
perimeter P. The line handling system 10 further comprises an actuatable coupling 
mechanism 200 for coupling the line of the marine vessel to a second line when the line 
of the marine vessel is at the predetermined region R of the perimeter P.  
[Figure 5]
5/10 
u
0I~
Patent AU-2021247584-B2 (AU)
Title: Sialic acid compositions for use in inhibiting and treating coronavirus infection
Inventor: REMMEREIT JAN
IPC: A61K31/7012
Filed: 2021-03-31
Granted: 2023-11-02
Abstract: The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
Patent AU-2021266354-B2 (AU)
Title: Generator and a catheter with an electrode and a method for treating a lung passageway
Inventor: WALDSTREICHER JONATHAN REUBEN
IPC: A61B18/12
Filed: 2021-11-12
Granted: 2023-07-27
Abstract: OF THE DISCLOSURE 
Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery 
of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue 
modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without 
limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal 
cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, 
nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be 
used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic 
bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary 
ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.  
-104-
Patent AU-2021332210-B2 (AU)
Title: Configurable fluid compression apparatus, control, and associated methods
Inventor: SAHM DOUGLAS A
IPC: F15B11/16
Filed: 2021-08-24
Granted: 2024-01-25
Abstract: An apparatus to transfer a fluid from a fluid inlet to a fluid outlet is disclosed herein. An example apparatus includes a first compressor unit and a second compressor unit fluidly coupled between the first and second locations, and a valve coupled between the first and second compressor units, the valve to switch between a first state and a second state, the fluid to flow through the first and second compressor units in a parallel configuration when the valve is in the first state, the fluid to flow through the first and second compressor units in a series configuration when the valve is in the second state.
Patent AU-2022201400-B2 (AU)
Title: Bluetooth glasses
Inventor: CHENG HSI-CHOU
IPC: G10K11/18
Filed: 2022-03-01
Granted: 2023-09-28
Abstract: A pair of Bluetooth glasses is revealed. The Bluetooth glasses 
includes a glasses body with a first assembly portion disposed on a rear 
end of a temple thereof, a Bluetooth earphone having a second assembly 
portion arranged at a front end of an earphone body thereof, and a 
connection member. The second assembly portion is mounted into one 
end of a sleeve of the connection member while the first assembly portion 
on the temple is mounted into the other end of the sleeve. Thereby the 
temple is assembled with the Bluetooth earphone conveniently and 
various combinations of materials such as metals and plastic are used to 
increase Bluetooth glasses styles. Moreover, an adjustment knob is 
mounted to the earphone body of the Bluetooth earphone for switching 
between a front broadcast hole and a rear broadcast hole through which 
sounds from a speaker are output.
1/17 
C.0o 
'"I 
CoN 
C*41 
CN I
Patent JP-3955724-B2 (JP)
IPC: H01L21/673
Filed: 2000-10-12
Granted: 2007-08-08
Abstract: A sealed type container accommodating a semiconductor substrate is positioned to a load port of a semiconductor manufacturing apparatus. The semiconductor substrate is taken out of the container. An ionizer is used for static-charge-eliminating the semiconductor substrates before and after process treatment in a transport area between the load port and a treatment section. The static-charge-eliminated semiconductor substrate is accommodated in the container positioned to the load port. Thus, it is possible to decrease foreign materials adhering to the semiconductor substrate and errors in handling the semiconductor substrate.
Patent JP-4145012-B2 (JP)
IPC: G01B11/00
Filed: 2000-12-11
Granted: 2008-09-03
Abstract: Enabling placing a mark at a position selected as desired easily and quickly without the possibility of forming damages on the lens is disclosed. A method comprises the step of measuring a lens in which the optical properties and the reference position of the spectacle lens are measured and the step of processing in which the lens is processed based on the optical information obtained in the step of measuring a lens. In the step of measuring a lens, the optical properties such as the prism value of the lens are measured using a position selected as desired in an uncut lens as the position of the measurement, an optical reference position such as the position of the optical center is calculated from the result of the measurement, a mark is placed at the obtained position and the relation between the position of the mark and the optical reference position is memorized, recorded or transferred to another instrument. In the step of processing, the position of the mark is detected and specified, the reference position such as the position of the optical center is specified based on the position of the mark and the data which have been memorized, recorded or transferred and the lens is processed. <IMAGE>
Patent JP-4215393-B2 (JP)
IPC: G06F11/20
Filed: 1998-12-15
Granted: 2009-01-28
Abstract: In addition to one or more subassemblies, an extra identical subassembly is provided. A multiplexer is connected to the inputs to the subassembly and connects the input bus of one subassembly to the following subassembly. The outputs of the subassembly are connected to a multiplexer which receives the output bus of each subassembly from the respective following subassembly. In the event of a defect in one of the subassemblies, the multiplexers are switched to replace the faulty subassembly with the following one, and so on unit the last subassembly is replaced by the extra subassembly.
Patent JP-3710381-B2 (JP)
IPC: A61M5/20
Filed: 1999-04-24
Granted: 2005-10-26
Abstract: An injection device that is used with a syringe, wherein the injection needle of the syringe is initially introduced into the skin and the injection fluid is injected afterwards. The injection device is essentially driven and controlled by a control sleeve (6) which can be displaced and/or rotated in relation to the housing (7) and which can be moved between a closing and functional position (P1) and an open and safety position (P2). In the closing and functional position, the control sleeve prevents access to the syringe and activates a release device for the injection process. In the open and safety position, a syringe (1) can be removed or inserted. A plurality of components carrying out the injection process (a slide (2) in which the syringe (1) is placed and a plunger (4) that impinges upon the syringe piston) are moved or controlled depending on the movement and position of the control sleeve or supported (for example, an ejection device for the syringe or a signaling device informing that injection has been completed). The device enables full-automatic injection that can be reliably carried out by patients themselves with few handling procedures.
Patent JP-4420562-B2 (JP)
IPC: G10L19/012
Filed: 1999-05-04
Granted: 2010-02-24
Abstract: A system and method to improve the quality of coded speech coexisting with background noise. For instance, the present invention receives a coded speech signal via a communication network and then decodes and synthesizes the different parameters contained within it to produce a synthesized speech signal. The present invention determines the non-speech periods that are represented within the synthesized speech signal. The determined non-speech periods are then utilized to determine and code LPC parameters needed for background noise synthesis. Because medium or low bit rate LPC-coded speech during voice activity periods has the coexisting background noise attenuated, the decoded signal has audible abrupt changes in the level of the background noise. To improve decoded speech quality, the present invention adds simulated background noise to decoded noisy speech when synthesizing the noisy speech signal during voice activity periods. The resulting output signal sounds more natural and realistic to the human ear because of the continuous presence of background noise during speech and non-speech periods.
Patent JP-4455756-B2 (JP)
IPC: A61B5/022
Filed: 1999-06-02
Granted: 2010-04-21
Abstract: A probe for application to a body part particularly a finger of a patent to detect a change in the physical condition of the patient includes a housing defining a compartment closed at one end and open at the opposite end for receiving the distal end of the patient's finger and a medium wholly self-contained within the probe for applying a static pressure field substantially uniformly around the distal end of the patient's finger, of a predetermined magnitude sufficient to substantially prevent distention of the venous vasculature, uncontrolled venous backflow, and retrograde shockwave propagation into the distal end, and to partially unload the wall tension of, but not to occlude, the arteries in the distal end when at heart level or below. A sensor senses changes in the distal end of the patient's finger related to changes in arterial blood volume therein.
Patent JP-4489297-B2 (JP)
IPC: A61F2/07
Filed: 1999-09-09
Granted: 2010-06-23
Abstract: The present invention relates to a composition comprising heparin to be used as a non-thrombogenic surface when in contact with arterial blood flow. It also relates to a device treated on the surface thereof with such a composition.
Patent JP-4299467-B2 (JP)
IPC: G02B6/028
Filed: 1999-08-23
Granted: 2009-07-22
Abstract: The present invention relates to an optical single-mode fiber having low dispersion for the wavelength division multiplex operation (WDM) of an optical transmission path, which is made of a central fiber core having the radius r1, two inner fiber cladding layers having the outer radius r2 and a, respectively, where a>r2, and an outer fiber cladding layer, the refractive index profile n(r) of the fiber not being constant as a function of the fiber radius r (triple-clad fiber). By properly selecting the profile form and the refractive index differences between the core layers and cladding layers, respectively, conventional fabrication methods can be used to manufacture a fiber having low dispersion within the wavelength range of about 1400 to 1700 nm and, thus, in the third optical window, fiber attenuation not being increased thereby.
Patent JP-4383671-B2 (JP)
IPC: C12Q1/68
Filed: 1999-12-06
Granted: 2009-12-16
Abstract: The amino acid and nucleic acid sequences of a  DELTA <5>-desaturase enzyme and a  DELTA <8>-desaturase enzyme are disclosed. The nucleic acid sequences can be used to design recombinant DNA constructs and vectors. These vectors can then be used to transform various organisms, including for example, plants and yeast. The transformed organisms will then produce polyunsaturated fatty acids. The amino acid sequences are useful for generating enzyme-specific antibodies that are useful for identifying the desaturases.
Patent JP-4646405-B2 (JP)
IPC: G01F1/20
Filed: 2000-01-14
Granted: 2011-03-09
Abstract: A low-flow metering device 10 for measuring the flow of an amount of liquid exceeding 0.05 ml., in which a first chamber 12 has an inlet 14, and an outlet 16 in fluid communication with a second chamber 17, the first chamber 12 containing an element 22 creating a laminar flow 24. The outlet 16 of the first chamber is provided with a drop generator 19 leading to the second chamber 17 and is sized to release a series of droplets 18, each of the droplets forming and breaking away under its own weight from liquid in the drop generator orifice. An overflow conduit 21 extends between an upper area of the first chamber 12 and a lower area of the second chamber 17 for equalizing gas pressure between the two chambers 12, 17. An electronic system 28 is positioned in the second chamber 17 below the drop generator 19 for counting the passage of each droplet 18 exiting therefrom, and an information processing unit 32 is connected to the electronic system 28 for receiving and recording information.
Patent JP-3933889-B2 (JP)
IPC: C07D401/04
Filed: 2001-06-28
Granted: 2007-06-20
Abstract: Heterocyclic-substituted N,N'-diphenylurea derivatives (I) are new.   Urea derivatives of formula (I) and their enantiomers, diastereomers and acid or base addition salts are new. R1 - R4 = H, halo, alkyl, alkoxy, OH, alkylthio, SH, CN, NH2, mono- or dialkylamino, NO2, COOH, alkoxycarbonyl, CONH2 or mono- or dialkylaminocarbonyl; or two adjacent groups together complete a fused benzene ring or a 5-7 membered heteroaryl ring containing 1-3 of N, O and/ore S as heteroatoms; L1, L2 = H or together form CH2CH2; X1 = direct bond (bonded in the 2- or 3-position of the ring); and X2 = H, halo, alkyl, alkoxy, OH, NO2, CN, NH2 or mono- or dialkylamino; or X1 + X2 = group forming a 4-7C ring with the C atoms in the 3- and 4-positions of the ring, 1 or 2 CH2 units of the ring optionally being replaced by O, NH or N(alkyl) and G being bonded to a ring C; X3 = H, halo, alkyl, alkoxy, OH, NO2, CN, NH2 or mono- or dialkylamino; G = heterocyclic group of formula (G1)-(G3); dotted line = optional bond; Alk = 1-6C alkylene, which must be bonded at the 2-position in an imidazoline ring of (G1); n, m = 0 or 1; T3, T4 = alkyl; or aryl, arylalkyl, heteroaryl or heteroarylalkyl (all optionally ring-substituted by one or more of halo, alkyl, alkoxy, OH, SH, alkylthio, CN, NH2, mono- or dialkylamino, NO2, COOH, alkoxycarbonyl, CONH2 or mono- or dialkylaminocarbonyl; heteroaryl rings may additionally be mono-substituted by oxo); aryl moieties = phenyl, naphthyl or biphenylyl; heteroaryl moieties = mono- or bicyclic group in which at least one ring is aromatic, containing 1-5 of N, O and/or S as heteroatom(s); alkyl moieties have 1-6C. Independent claims are included for the preparation of (I).
Patent JP-4786825-B2 (JP)
IPC: H01H33/42
Filed: 2001-07-02
Granted: 2011-10-05
Abstract: The actuator rod, comprising an insulator (7) with metal fittings (8, 9) fixed to its two ends, has a thermal shield (10) of an electrical insulating material between the armatures, set at a distance from the insulator to form a free annular gap (11). The gap can be filled with the dielectric insulating gas used in the cut-out, but at a different pressure.
Patent JP-3593100-B2 (JP)
IPC: H04L29/06
Filed: 1999-09-07
Granted: 2004-11-24
Abstract: A method for performing a lawful interception in a packet network comprises the steps of generating (S 2 ) interception related information packets from a communication to be intercepted; generating (S 2 ) communication content packets from a communication to be intercepted; providing (S 3 ) identification data for the interception related information packets and for the communication content packets of one group of communication packets; providing (S 5 ) ordering data for each of the interception related information data packets and for each of the communication content packets; and transmitting (S 6 ) the interception related information packets, the communication packets, the identification data and the ordering data to an interception authority device. By this measure, a missequenced reception of interception related information (IRI) packets and communication content (CC) packets can be avoided. Also, the assembly of IRI packets between corresponding CC packets is possible by a corresponding LEMF of the interception authority.
Patent JP-5362937-B2 (JP)
IPC: A61L27/00
Filed: 2000-09-14
Granted: 2013-12-11
Abstract: A non-crosslinked, decellularized and purified mammalian tissue (e.g., bovine pericardium) having particular use as an implantable resorbable material. The material is treated by alkylating its primary amine groups in a manner sufficient to reduce the antigenicity of the tissue, permitting the treated tissue to be used in vivo and without crosslinking, and in turn, permitting it to be resorbable. The material can be used in surgical repair of soft tissue deficiencies for a certain period of time while the implant itself is gradually remodeled or absorbed by the host. Also provided are a method of preparing such a material, as well as a method of using such a material for surgical repair.